Bio-Functional Mesoporous Silica Nanoparticles as Nano-Structured Carriers in Cancer Theranostic Review on Recent Advancements
CONCLUSION: Mesoporous silica nanoparticles are great carriers for intracellular and targeted drug delivery systems.PMID:37592775 | DOI:10.2174/1389450124666230817103122 (Source: Current Drug Targets)
Source: Current Drug Targets - August 18, 2023 Category: Drugs & Pharmacology Authors: Darshan Gevariya Lipika Priya Smit Mehta Vishwas Patel Dhara Bhuva Drishti Panjwani Shruti Patel Priyanka Ahlawat Abhay Dharamsi Asha Patel Source Type: research

A Comprehensive Review on Therapeutic Potential of a Natural Anthraquinone Derivative Emodin in Brain-related Disorders
Curr Drug Targets. 2023 Aug 18. doi: 10.2174/1389450124666230818092506. Online ahead of print.ABSTRACTBrain-related disorders are one of the world's most important and complex health problems today. These brain-related disorders are responsible for a massive number of morbidities and death all around the world. However, researchers have devoted a large amount of time to investigating these diseases and found positive results; nevertheless, there are currently quite a few medications available to treat them. Emodin (EM), a polyphenol compound, has many health benefits. It is a biologically active monomer derived from rhubar...
Source: Current Drug Targets - August 18, 2023 Category: Drugs & Pharmacology Authors: Ahsas Goyal Yogesh Murti Bharat Bhushan Wasim Chisti Ashutosh Solanki Source Type: research

Bio-Functional Mesoporous Silica Nanoparticles as Nano-Structured Carriers in Cancer Theranostic Review on Recent Advancements
CONCLUSION: Mesoporous silica nanoparticles are great carriers for intracellular and targeted drug delivery systems.PMID:37592775 | DOI:10.2174/1389450124666230817103122 (Source: Current Drug Targets)
Source: Current Drug Targets - August 18, 2023 Category: Drugs & Pharmacology Authors: Darshan Gevariya Lipika Priya Smit Mehta Vishwas Patel Dhara Bhuva Drishti Panjwani Shruti Patel Priyanka Ahlawat Abhay Dharamsi Asha Patel Source Type: research

Estimating the survival rate in glioblastoma multiforme patients who received a peptide vaccine: a systematic review and meta-analysis
CONCLUSION: Our study found that while peptide vaccination treatment did not increase second-year survival, it improved first-year survival. More research needs to be done to find effective vaccine-based treatments for GBM that can help patients survive longer.PMID:37587807 | DOI:10.2174/1389450124666230816114131 (Source: Current Drug Targets)
Source: Current Drug Targets - August 17, 2023 Category: Drugs & Pharmacology Authors: Masoumeh Eliyasi Dashtaki Zahra Moradi Yousef Moradi Elham Asadi Sorayya Ghasemi Source Type: research

Structural Modifications in Chitosan Polymer Carries Synergistic Transfection in Drug Targeting
Curr Drug Targets. 2023 Aug 16. doi: 10.2174/1389450124666230816153247. Online ahead of print.NO ABSTRACTPMID:37584356 | DOI:10.2174/1389450124666230816153247 (Source: Current Drug Targets)
Source: Current Drug Targets - August 16, 2023 Category: Drugs & Pharmacology Authors: Dilpreet Singh Neena Bedi Pooja Chawla Source Type: research

Structural Modifications in Chitosan Polymer Carries Synergistic Transfection in Drug Targeting
Curr Drug Targets. 2023 Aug 16. doi: 10.2174/1389450124666230816153247. Online ahead of print.NO ABSTRACTPMID:37584356 | DOI:10.2174/1389450124666230816153247 (Source: Current Drug Targets)
Source: Current Drug Targets - August 16, 2023 Category: Drugs & Pharmacology Authors: Dilpreet Singh Neena Bedi Pooja Chawla Source Type: research

Cytotoxic flavokawain B inhibits the growth and metastasis of hepatocellular carcinoma through UCK2 modulation of the STAT3/Hif-1 α/VEGF signalling pathway
CONCLUSION: Our data suggest that FKB inhibited HepG2 proliferation and further suppressed its metastasis partly by regulating the STAT3/Hif-1α/VEGF signalling pathway. FKB could be a potential alternative and viable strategy against HCC.PMID:37534791 | DOI:10.2174/1389450124666230803153750 (Source: Current Drug Targets)
Source: Current Drug Targets - August 3, 2023 Category: Drugs & Pharmacology Authors: Ibrahim Malami Alhassan Alhassan Adamu Adamu Muhammad Bello Aliyu Muhammad Mustapha Imam Source Type: research

Cytotoxic flavokawain B inhibits the growth and metastasis of hepatocellular carcinoma through UCK2 modulation of the STAT3/Hif-1 α/VEGF signalling pathway
CONCLUSION: Our data suggest that FKB inhibited HepG2 proliferation and further suppressed its metastasis partly by regulating the STAT3/Hif-1α/VEGF signalling pathway. FKB could be a potential alternative and viable strategy against HCC.PMID:37534791 | DOI:10.2174/1389450124666230803153750 (Source: Current Drug Targets)
Source: Current Drug Targets - August 3, 2023 Category: Drugs & Pharmacology Authors: Ibrahim Malami Alhassan Alhassan Adamu Adamu Muhammad Bello Aliyu Muhammad Mustapha Imam Source Type: research

Cytotoxic flavokawain B inhibits the growth and metastasis of hepatocellular carcinoma through UCK2 modulation of the STAT3/Hif-1 α/VEGF signalling pathway
CONCLUSION: Our data suggest that FKB inhibited HepG2 proliferation and further suppressed its metastasis partly by regulating the STAT3/Hif-1α/VEGF signalling pathway. FKB could be a potential alternative and viable strategy against HCC.PMID:37534791 | DOI:10.2174/1389450124666230803153750 (Source: Current Drug Targets)
Source: Current Drug Targets - August 3, 2023 Category: Drugs & Pharmacology Authors: Ibrahim Malami Alhassan Alhassan Adamu Adamu Muhammad Bello Aliyu Muhammad Mustapha Imam Source Type: research

Cytotoxic flavokawain B inhibits the growth and metastasis of hepatocellular carcinoma through UCK2 modulation of the STAT3/Hif-1 α/VEGF signalling pathway
CONCLUSION: Our data suggest that FKB inhibited HepG2 proliferation and further suppressed its metastasis partly by regulating the STAT3/Hif-1α/VEGF signalling pathway. FKB could be a potential alternative and viable strategy against HCC.PMID:37534791 | DOI:10.2174/1389450124666230803153750 (Source: Current Drug Targets)
Source: Current Drug Targets - August 3, 2023 Category: Drugs & Pharmacology Authors: Ibrahim Malami Alhassan Alhassan Adamu Adamu Muhammad Bello Aliyu Muhammad Mustapha Imam Source Type: research

Cytotoxic flavokawain B inhibits the growth and metastasis of hepatocellular carcinoma through UCK2 modulation of the STAT3/Hif-1 α/VEGF signalling pathway
CONCLUSION: Our data suggest that FKB inhibited HepG2 proliferation and further suppressed its metastasis partly by regulating the STAT3/Hif-1α/VEGF signalling pathway. FKB could be a potential alternative and viable strategy against HCC.PMID:37534791 | DOI:10.2174/1389450124666230803153750 (Source: Current Drug Targets)
Source: Current Drug Targets - August 3, 2023 Category: Drugs & Pharmacology Authors: Ibrahim Malami Alhassan Alhassan Adamu Adamu Muhammad Bello Aliyu Muhammad Mustapha Imam Source Type: research

Cytotoxic flavokawain B inhibits the growth and metastasis of hepatocellular carcinoma through UCK2 modulation of the STAT3/Hif-1 α/VEGF signalling pathway
CONCLUSION: Our data suggest that FKB inhibited HepG2 proliferation and further suppressed its metastasis partly by regulating the STAT3/Hif-1α/VEGF signalling pathway. FKB could be a potential alternative and viable strategy against HCC.PMID:37534791 | DOI:10.2174/1389450124666230803153750 (Source: Current Drug Targets)
Source: Current Drug Targets - August 3, 2023 Category: Drugs & Pharmacology Authors: Ibrahim Malami Alhassan Alhassan Adamu Adamu Muhammad Bello Aliyu Muhammad Mustapha Imam Source Type: research

Cytotoxic flavokawain B inhibits the growth and metastasis of hepatocellular carcinoma through UCK2 modulation of the STAT3/Hif-1 α/VEGF signalling pathway
CONCLUSION: Our data suggest that FKB inhibited HepG2 proliferation and further suppressed its metastasis partly by regulating the STAT3/Hif-1α/VEGF signalling pathway. FKB could be a potential alternative and viable strategy against HCC.PMID:37534791 | DOI:10.2174/1389450124666230803153750 (Source: Current Drug Targets)
Source: Current Drug Targets - August 3, 2023 Category: Drugs & Pharmacology Authors: Ibrahim Malami Alhassan Alhassan Adamu Adamu Muhammad Bello Aliyu Muhammad Mustapha Imam Source Type: research

Cytotoxic flavokawain B inhibits the growth and metastasis of hepatocellular carcinoma through UCK2 modulation of the STAT3/Hif-1 α/VEGF signalling pathway
CONCLUSION: Our data suggest that FKB inhibited HepG2 proliferation and further suppressed its metastasis partly by regulating the STAT3/Hif-1α/VEGF signalling pathway. FKB could be a potential alternative and viable strategy against HCC.PMID:37534791 | DOI:10.2174/1389450124666230803153750 (Source: Current Drug Targets)
Source: Current Drug Targets - August 3, 2023 Category: Drugs & Pharmacology Authors: Ibrahim Malami Alhassan Alhassan Adamu Adamu Muhammad Bello Aliyu Muhammad Mustapha Imam Source Type: research

Cytotoxic flavokawain B inhibits the growth and metastasis of hepatocellular carcinoma through UCK2 modulation of the STAT3/Hif-1 α/VEGF signalling pathway
CONCLUSION: Our data suggest that FKB inhibited HepG2 proliferation and further suppressed its metastasis partly by regulating the STAT3/Hif-1α/VEGF signalling pathway. FKB could be a potential alternative and viable strategy against HCC.PMID:37534791 | DOI:10.2174/1389450124666230803153750 (Source: Current Drug Targets)
Source: Current Drug Targets - August 3, 2023 Category: Drugs & Pharmacology Authors: Ibrahim Malami Alhassan Alhassan Adamu Adamu Muhammad Bello Aliyu Muhammad Mustapha Imam Source Type: research